年龄对Na:K比率的影响:来自一般犬种群的观察
Polina Zemko1, Federico Bonsembiante1, Marco Canevelli2
1Department of Animal Medicine, Productions and Health, University of Padua, Legnaro, Italy.
Frontiers in veterinary science
|November 10, 2025
概括
与 (Na:K) 的比率,一种用于选犬类低皮质症 (HA) 的查工具,随着年龄的增长而变得不那么可靠. 血清与年龄相关的增加,受血小板的影响,降低老犬的Na:K比率.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 内分泌学 在内分泌学.
- 狗的健康 狗的健康
背景情况:
- 与 (Na:K) 的比率是犬类低 adrenocorticism (HA) 的常见查标准.
- 低于27的Na:K比率通常会触发进一步的上腺功能测试.
- 健康狗的血清 (K) 水平可能随着年龄的增长而增加,这可能会影响Na:K比的诊断效用.
研究的目的:
- 评估年龄对狗的Na:K比率的影响.
- 为了确定与年龄相关的变化是否会影响Na:K比率作为成年和老年狗中HA的查工具的可靠性.
主要方法:
- 对208只年龄在5-16岁的狗的生化和血液学数据进行了分析.
- 在12个月的随访期内进行纵向数据收集.
- 血清Na,K和血小板血 (PCT) 的与年龄相关趋势的评估.
主要成果:
- 与年轻狗 (2.4%) 相比,10岁以上的狗 (12.8%) 的Na:K比率≤27的狗的患病率显著增加.
- 血清K水平随着年龄的增加 (0.22mEq/L每5年),而Na水平保持稳定,导致Na:K比率下降.
- 血清K与PCT的相关性中等,这也随着年龄的增长而增加,这表明血小板会影响与年龄相关的K变化.
结论:
- 在老犬中,Na:K比值≤27的值对诊断HA的特异性较低,因为与年龄相关的血清K值增加.
- 与年龄相关的PCT增加有助于老年狗的Na:K比率降低.
- 作为HA的唯一查标准,Na:K比率的可靠性可能会在老犬种群中受到损害.
相关概念视频
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
226
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
226
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
221
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
221
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
01:29Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
213
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
213
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
188
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
188